October 30, 2026 QFIN Investors Have Opportunity to Lead Qfin Holdings, Inc. Securities Fraud Lawsuit
October 30, 2026 INOVIO Announces FDA Accelerated Approval of VOCERYQ™, an Immunotherapy to Reduce the Frequency of Surgery in Adults with Recurrent Respiratory Papillomatosis (RRP)